| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.064 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |